SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-061429
Filing Date
2019-12-20
Accepted
2019-12-20 08:13:22
Documents
2
Period of Report
2016-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1521
2 EX-24 DOCUMENT attachment1.htm EX-24 4784
  Complete submission text file 0001209191-19-061429.txt   7736
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Alles Mark J (Reporting) CIK: 0001538897 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37813 | Film No.: 191297694

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations